Display options
Cite
Brown MB, Hunt WR, Noe JE, et al. Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke. Pulm Circ. 2014;4(2):260-8doi: 10.1086/675989.
Brown, M. B., Hunt, W. R., Noe, J. E., Rush, N. I., Schweitzer, K. S., Leece, T. C., Moldobaeva, A., Wagner, E. M., Dudek, S. M., Poirier, C., Presson, R. G., Gulbins, E., & Petrache, I. (2014). Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke. Pulmonary circulation, 4(2), 260-8. https://doi.org/10.1086/675989
Brown, Mary Beth, et al. "Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke." Pulmonary circulation vol. 4,2 (2014): 260-8. doi: https://doi.org/10.1086/675989
Brown MB, Hunt WR, Noe JE, Rush NI, Schweitzer KS, Leece TC, Moldobaeva A, Wagner EM, Dudek SM, Poirier C, Presson RG, Gulbins E, Petrache I. Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke. Pulm Circ. 2014 Jun;4(2):260-8. doi: 10.1086/675989. PMID: 25006445; PMCID: PMC4070785.
Copy Download .nbib Format: NLM
Share it on

Pulm Circ. 2014 Jun;4(2):260-8. doi: 10.1086/675989.

Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke.

Pulmonary circulation

Mary Beth Brown, William R Hunt, Julie E Noe, Natalia I Rush, Kelly S Schweitzer, Thomas C Leece, Aigul Moldobaeva, Elizabeth M Wagner, Steven M Dudek, Christophe Poirier, Robert G Presson, Erich Gulbins, Irina Petrache

Affiliations

  1. Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA ; Department of Physical Therapy, School of Health and Rehabilitation Sciences, Indiana University, Indianapolis, Indiana, USA.
  2. Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
  3. Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  4. Department of Medicine, University of Illinois, Chicago, Illinois, USA.
  5. Department of Anesthesia, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
  6. Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA ; Richard L. Roudebush Veteran Affairs Medical Center, Indianapolis, Indiana, USA.

PMID: 25006445 PMCID: PMC4070785 DOI: 10.1086/675989

Abstract

Abnormal lung microvascular endothelial vascular barrier function may contribute to pulmonary inflammation, such as that occurring during inhalation of cigarette smoke (CS). Cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel expressed in both epithelial and endothelial cells, regulates the organization of tight junctions between epithelial cells and has also been implicated in the transport of sphingosine-1 phosphate (S1P), a vascular barrier-enhancing sphingolipid. Because CS has been shown to affect CFTR function, we hypothesized that CFTR function contributes to lung endothelial cell barrier and that CFTR dysfunction worsens CS-induced injury. CFTR inhibitors GlyH-101 or CFTRinh172 caused a dose-dependent increase in pulmonary or bronchial endothelial monolayer permeability, which peaked after 4 hours. CFTR inhibition was associated with both intercellular gaps and actin stress fiber formation compared with vehicle-treated cells. Increasing endothelial S1P, either by exogenous treatment or by inhibition of its degradation, significantly improved the barrier function in CFTR-inhibited monolayers. Both cultured lung endothelia and the lung microcirculation visualized in vivo with intravital two-photon imaging of transgenic mice deficient in CFTR showed that CFTR dysfunction increased susceptibility to CS-induced permeability. These results suggested that CFTR function might be required for lung endothelial barrier, including adherence junction stability. Loss of CFTR function, especially concomitant to CS exposure, might promote lung inflammation by increasing endothelial cell permeability, which could be ameliorated by S1P.

Keywords: COPD; S1P; ceramides; cystic fibrosis; sphingolipids

References

  1. Am J Respir Cell Mol Biol. 2009 Sep;41(3):314-23 - PubMed
  2. Respir Res. 2009 Nov 27;10:120 - PubMed
  3. BMC Dev Biol. 2008 Jul 06;8:70 - PubMed
  4. Microvasc Res. 2004 Mar;67(2):139-51 - PubMed
  5. FASEB J. 2012 Feb;26(2):533-45 - PubMed
  6. Am J Physiol Lung Cell Mol Physiol. 2011 Dec;301(6):L836-46 - PubMed
  7. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):223-32 - PubMed
  8. Am J Respir Crit Care Med. 2011 Jun 15;183(12):1660-5 - PubMed
  9. Chest. 2013 Aug;144(2):498-506 - PubMed
  10. Am J Respir Crit Care Med. 2006 May 15;173(10):1139-44 - PubMed
  11. Blood. 2012 Feb 16;119(7):1757-67 - PubMed
  12. Lab Invest. 2012 Nov;92(11):1527-40 - PubMed
  13. J Physiol. 2010 Apr 15;588(Pt 8):1195-209 - PubMed
  14. PLoS One. 2012;7(6):e39809 - PubMed
  15. Am J Pathol. 2011 Jul;179(1):75-82 - PubMed
  16. J Pediatr Gastroenterol Nutr. 1982;1(3):355-9 - PubMed
  17. Nat Med. 2008 Apr;14(4):382-91 - PubMed
  18. J Biol Chem. 2001 Sep 21;276(38):35258-64 - PubMed
  19. Nat Rev Mol Cell Biol. 2003 May;4(5):397-407 - PubMed
  20. J Gen Physiol. 2002 Feb;119(2):199-207 - PubMed
  21. Nat Med. 2012 Apr 05;18(4):509-19 - PubMed
  22. J Clin Invest. 2001 Sep;108(5):689-701 - PubMed
  23. Am J Physiol Lung Cell Mol Physiol. 2002 Sep;283(3):L520-7 - PubMed
  24. Chest. 2000 Jan;117(1):163-8 - PubMed
  25. Am J Physiol Lung Cell Mol Physiol. 2011 Jun;300(6):L840-50 - PubMed
  26. J Pediatr. 2005 Sep;147(3 Suppl):S37-41 - PubMed
  27. Am J Physiol Lung Cell Mol Physiol. 2006 Mar;290(3):L588-96 - PubMed
  28. Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L894-902 - PubMed
  29. Gastroenterology. 2005 Aug;129(2):665-81 - PubMed

Publication Types

Grant support